Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016296873> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2016296873 endingPage "763" @default.
- W2016296873 startingPage "759" @default.
- W2016296873 abstract "To better understand the factors that affect low disease activity (DAS28 ≤ 3.2, LDA) in rheumatoid arthritis (RA) and barriers within the UAE, demographic/treatment data and DAS28 scores were collected through chart reviews of 182 consecutive RA patients seen at a private clinic in Dubai over a 2-month period. Patients were separated into a LDA group and a group comprised of moderate (3.2 < DAS28 < 5.1) or high disease activity (DAS28 ≥ 5.1) (MHDA). We then examined variables that may be associated with LDA and re-examined the MHDA group for barriers. While 97 (53 %) of the 182 patients had achieved the treatment target of DAS28 ≤ 3.2, 85 (47 %) had MHDA. A significantly larger portion of LDA patients had been previously treated with sulfasalazine (36 in LDA vs. 14 in MHDA, P = 0.002) or was presently on biological treatments (24 vs. 9, P = 0.013). For the 85 MHDA patients, 40 (22 % of 182) exhibited resistant disease with 25 (13.7 % of 182) failing their current first tier disease-modifying anti-rheumatic drug (DMARD) treatment or combinations and 15 (8.2 % of 182) failing current anti-TNF or biologic treatment. Reasons listed were primarily socioeconomic with 40 % of the resistant disease group unable to afford biologicals and 52 % of the patient-driven preference group discontinuing DMARDs against professional advice. Going forward, emphasis on the agreement between patient and rheumatologist on treatment, specifically regarding how DMARDs help relieve symptoms and their proper use, could help reduce the percentage of MHDA patients in the UAE." @default.
- W2016296873 created "2016-06-24" @default.
- W2016296873 creator A5011354554 @default.
- W2016296873 creator A5015865003 @default.
- W2016296873 creator A5052646206 @default.
- W2016296873 date "2014-10-15" @default.
- W2016296873 modified "2023-09-26" @default.
- W2016296873 title "Barriers to achieving controlled rheumatoid arthritis in the United Arab Emirates: a cross-sectional study" @default.
- W2016296873 cites W1994865061 @default.
- W2016296873 cites W1996389186 @default.
- W2016296873 cites W2098889063 @default.
- W2016296873 cites W2099334955 @default.
- W2016296873 cites W2111153776 @default.
- W2016296873 cites W2111390740 @default.
- W2016296873 cites W2128713459 @default.
- W2016296873 cites W2146166312 @default.
- W2016296873 cites W2155109530 @default.
- W2016296873 cites W2170844369 @default.
- W2016296873 cites W2763284518 @default.
- W2016296873 cites W3006080604 @default.
- W2016296873 cites W4249063051 @default.
- W2016296873 cites W4252663040 @default.
- W2016296873 doi "https://doi.org/10.1007/s00296-014-3151-7" @default.
- W2016296873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25315703" @default.
- W2016296873 hasPublicationYear "2014" @default.
- W2016296873 type Work @default.
- W2016296873 sameAs 2016296873 @default.
- W2016296873 citedByCount "4" @default.
- W2016296873 countsByYear W20162968732018 @default.
- W2016296873 countsByYear W20162968732019 @default.
- W2016296873 countsByYear W20162968732022 @default.
- W2016296873 crossrefType "journal-article" @default.
- W2016296873 hasAuthorship W2016296873A5011354554 @default.
- W2016296873 hasAuthorship W2016296873A5015865003 @default.
- W2016296873 hasAuthorship W2016296873A5052646206 @default.
- W2016296873 hasBestOaLocation W20162968732 @default.
- W2016296873 hasConcept C126322002 @default.
- W2016296873 hasConcept C142052008 @default.
- W2016296873 hasConcept C142724271 @default.
- W2016296873 hasConcept C1862650 @default.
- W2016296873 hasConcept C198451711 @default.
- W2016296873 hasConcept C2777575956 @default.
- W2016296873 hasConcept C2779134260 @default.
- W2016296873 hasConcept C2779383735 @default.
- W2016296873 hasConcept C2780479503 @default.
- W2016296873 hasConcept C71924100 @default.
- W2016296873 hasConceptScore W2016296873C126322002 @default.
- W2016296873 hasConceptScore W2016296873C142052008 @default.
- W2016296873 hasConceptScore W2016296873C142724271 @default.
- W2016296873 hasConceptScore W2016296873C1862650 @default.
- W2016296873 hasConceptScore W2016296873C198451711 @default.
- W2016296873 hasConceptScore W2016296873C2777575956 @default.
- W2016296873 hasConceptScore W2016296873C2779134260 @default.
- W2016296873 hasConceptScore W2016296873C2779383735 @default.
- W2016296873 hasConceptScore W2016296873C2780479503 @default.
- W2016296873 hasConceptScore W2016296873C71924100 @default.
- W2016296873 hasIssue "4" @default.
- W2016296873 hasLocation W20162968731 @default.
- W2016296873 hasLocation W20162968732 @default.
- W2016296873 hasLocation W20162968733 @default.
- W2016296873 hasOpenAccess W2016296873 @default.
- W2016296873 hasPrimaryLocation W20162968731 @default.
- W2016296873 hasRelatedWork W2117738981 @default.
- W2016296873 hasRelatedWork W2126275861 @default.
- W2016296873 hasRelatedWork W2164825415 @default.
- W2016296873 hasRelatedWork W2357697038 @default.
- W2016296873 hasRelatedWork W2408839319 @default.
- W2016296873 hasRelatedWork W2410978906 @default.
- W2016296873 hasRelatedWork W2536400801 @default.
- W2016296873 hasRelatedWork W2915456051 @default.
- W2016296873 hasRelatedWork W3037954360 @default.
- W2016296873 hasRelatedWork W4292632422 @default.
- W2016296873 hasVolume "35" @default.
- W2016296873 isParatext "false" @default.
- W2016296873 isRetracted "false" @default.
- W2016296873 magId "2016296873" @default.
- W2016296873 workType "article" @default.